Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis

Tumor tissues are often absent or insufficient for testing epidermal growth factor receptor (EGFR) mutations to guide EGFR tyrosine kinase inhibitors (TKIs) treatment of patients with nonsmall cell lung cancer (NSCLC). We conducted this systematic review and meta-analysis to assess whether blood can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore)
Hauptverfasser: Mao, Chen, Yuan, Jin-Qiu, Yang, Zu-Yao, Fu, Xiao-Hong, Wu, Xin-Yin, Tang, Jin-Ling
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Health 2015
Schlagworte:
5700
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4616411/
https://ncbi.nlm.nih.gov/pubmed/26020382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000775
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge